Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$842.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 5 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 6 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 29 most recent Form 4 transactions.
| Ligand Pharmaceuticals INC |
| MEXER◷◆ |
| 1,575 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 13 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 1,575 | $223.50 | $352K | -3.6% | Open the original filing on SEC.gov |
| May 13 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 1,575 | $69.51 | $109.5K | +3.8% | Open the original filing on SEC.gov |
| May 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷◆ | 459 | — | — | — | Open the original filing on SEC.gov |
| May 12 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 459 | $224.00 | $102.8K | -1.1% | Open the original filing on SEC.gov |
| May 12 | LGND | Ligand Pharmaceuticals INC | MEXER◷ | 459 | $69.51 | $31.9K | +1.1% | Open the original filing on SEC.gov |
| May 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 116 | $234.09 | $27.2K | -0.3% | Open the original filing on SEC.gov |
| May 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 105 | $232.57 | $24.4K | -0.3% | Open the original filing on SEC.gov |
| May 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 165 | $231.87 | $38.3K | -0.4% | Open the original filing on SEC.gov |
| May 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 1 | $229.87 | $230 | 0.0% | Open the original filing on SEC.gov |
| May 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 80 | $227.37 | $18.2K | -0.2% | Open the original filing on SEC.gov |
| Apr 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 159 | $204.26 | $32.5K | -0.4% | Open the original filing on SEC.gov |
| Apr 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 43 | $202.91 | $8.7K | -0.1% | Open the original filing on SEC.gov |
| Apr 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 79 | $202.42 | $16K | -0.2% | Open the original filing on SEC.gov |
| Apr 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 40 | $201.24 | $8K | <0.1% | Open the original filing on SEC.gov |
| Apr 1 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 146 | $199.97 | $29.2K | -0.3% | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 42 | $203.57 | $8.5K | -0.1% | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 50 | $202.54 | $10.1K | -0.1% | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 83 | $201.65 | $16.7K | -0.2% | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 41 | $200.40 | $8.2K | -0.1% | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 204 | $199.69 | $40.7K | -0.5% | Open the original filing on SEC.gov |
| Mar 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 47 | $197.14 | $9.3K | -0.1% | Open the original filing on SEC.gov |
| Feb 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 23 | $197.20 | $4.5K | <0.1% | Open the original filing on SEC.gov |
| Feb 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 381 | $196.36 | $74.8K | -0.9% | Open the original filing on SEC.gov |
| Feb 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 23 | $195.61 | $4.5K | <0.1% | Open the original filing on SEC.gov |
| Feb 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 1 | $192.18 | $192 | 0.0% | Open the original filing on SEC.gov |
| Feb 2 | LGND | Ligand Pharmaceuticals INC | SSELL◷ | 39 | $191.00 | $7.4K | <0.1% | Open the original filing on SEC.gov |